A single intravenous dose of tritiated digoxin was given to five obese patients before and after a mean loss of 102 pounds in weight. There were no significant differences in the blood concentrations of digoxin before and after the weight reduction. Likewise, there were no significant differences in the blood concentrations of digoxin when these data were corrected for fat-free body weight.
Additional Indexing Words: Fat-free body weight
Total body weight DIGOXIN has generally been prescribed in the adult without consideration of body size or weight.' However, Ewy and associates2 found a higher concentration of digoxin in the blood of elderly individuals of smaller body weight than in younger, heavier subjects, after a single intravenous dose of tritiated digoxin. The blood concentrations of digoxin of the two groups were not different when the data were corrected for body weight. It was, therefore, concluded that body weight is an important determinant of blood concentrations of digoxin. Jelliffe3 has likewise stressed the importance of body weight in determining digoxin dosage.
Very low concentrations of tritiated digoxin have been found in the adipose tissue in man (JE Doherty: Unpublished observations) and in the dog. 4 These findings suggest that lean body weight or fat-free body weight might be more important than total body weight in determining the blood concentration of digoxin.
The present study was designed to investigate further the influence of body weight on the blood concentration of digoxin in humans. To obviate the problem of subtle differences of digoxin metabolism among subjects, each obese subject was used as his own control and was studied before and after weight reduction.
Methods
Five obese subjects, ages 19 to 27 years, were hospitalized in the Clinical Study Unit of the Georgetown University Hospital for studies of change in body composition during dietary weight reduction under the supervision of one of the authors (M.B.).5
Informed consent was obtained from all subjects prior to the initiation of the study. Each subject's medical history was elicited, and physical examination was performed on admission to the hospital. Laboratory data obtained on admission included chest roentgenogram, electrocardiogram, hemogram, urinalysis, determination of blood urea nitrogen, serum creatinine, electrolytes, calcium, phosphorus, and glucose. The history, physical examination, and laboratory tests did not reveal any abnormalities except obesity. Laboratory studies performed periodically included serum electrolytes, blood urea nitrogen, and Clrculation, Volume XLlV, November 1971 seruim cr-eatininie. Mleasuremenits of total body wveight anid fat-free bodv weiglht were made on admllissioni, ser ially thlroughout the period of weighlt loss, and prior to discharge on each stubject bv methods previously described.5 All suibjects remaiined on the metabolic unit for 7 to 129 miionths durinig wvhich time they were given a lowx-calorie, liquid formula diet. Digoxin metabolism was sttudied at least twice in each subject, once at the beginning and once at the end of weight rieduction. An intermediate study was doine in thlee of the five subjects.
The digoxiin study was conducted as follows: a single, intravenous injection of 0.5 mg of tritiated digoxin* (specific activity, 144 uc/ml) as a 5% alcoholic solution in saline was given over a period of 1 minute. Zero time was taken as the end of the injection. Specimens of venous blood were obtaiined from the opposite antecubital vein 15, 30, anid 60 minutes and 2, 4, 6, 8, and 12 houirs after the injection and daily thereafter for 5 davs. The 24-hour endogenous clearances of *Tritiated digoxin was most kindly supplied by the Bulrrotighs Wellcome Company, Tuckahoe, New York. creatinine were calculated for each subject between the second and fourth day after digoxin was injected.
The concentration of digoxin was measured by methods previously reported from this laboratory.6 Briefly, the blood samples were extracted with 20% ethanol and chloroform. The solvent was evaporated and an aliquot was transferred to a counting solution. The recovery of radioactivity when tritiated digoxin was added to blood prior to extraction was 98.6 4.5% (mean + 1 standard deviation). Radioactivity of each specimen was counted on a model 314 EX Packard tricarb liquid scintillation counter. The counts were corrected for quenching by adding tritiated toluene of known activity and recounting. Differences in radioactivity between the two groups were analyzed using the two-tailed Student t-test.7 The rate of decrease in the concentration of digoxin before and after weight reduction was analyzed for possible significant differences by homogeneity of regression.8
Results
The age, sex, total and fat-free weights before and after weight reduction, and weight Meani concentration of digoxin ini blood at intervals followiing a single intravenous inijection of 0.5 mg of tritiated digoxin given to each of five obese subjects before (initial) and after (final) a mean individual loss of 102 pounds. Note that the digoxin concentrations are plotted on the ordinate in a semilogarithmic manner. There is no significant difference in the blood concentrations before and after loss of weight. losses are listed in table 1. The average age of five subjects was 22 years; average duration of hospitalization was 9 months; and the average loss of weight was 102 pounds, of which 22 pounds was loss of fat-free body weight. There was no significant difference in the creatinine clearance before and after weight loss ( 126 ± 10 versus 122 + 7 ml/ min).
Blood concentrations of digoxin and metabolites* before and after weight reduction were not significantly different after a single intravenous dose of tritiated digoxin (table 2; fig.  1 ). The blood digoxin half-life, calculated from 24 hours to the fifth day, was 58 hours before and 60 hours after weight loss. This difference was not significant. There was likewise no significant difference in the urinary excretion of digoxin before and after weight loss.
The lack of difference in the blood concen-*Hereafter, digoxin will refer to digoxin and metabolites. The concentration of digoxin in the blood is usually too small for satisfactory fractionation. However, extraction and partition chromatography of urine in patients previously studied indicates that nearly 90% of the radioactivity migrates with unchanged digoxin and the remainder with the cardioactive mletabolites digoxigenin monodigitoxosiide and digoxigenin bisdigitoxoside.9 Studies of the metabolism of tritiated digoxin in renal insufficiency in dogs and man indicate that the drug is likewise excreted primarily unchanged.10 tration of digoxin before and after weight reduction is best illustrated in patient F. F.
( fig. 2) , who lost the most weight-a total of 181 pounds. To determine whether the digoxin concentrations were related to fat-free body weight, the blood concentration of digoxin before and after weight reduction was calculated in terms of fat-free body weight. Again no significant differences were found. Discussion
We could not identify total body weight as a determinant of blood concentration of tritiated digoxin in these studies of obese subjects. As previously mentioned, our studies of digoxin metabolism in the elderly suggested that body weight is a determinant of blood concentration of digoxin.' In our earlier studies, the intravenous administration of tritiated digoxin resulted in blood concentrations during the first day that were higher in a group of elderly men (average weight, 143 + 25 pounds) as compared to the younger, heavier volunteers (average weight, 173 + 29 pounds). Although the creatinine and digoxin clearances were lower in the elderly men, these factors could not account for the higher blood concentrations of digoxin throughout the first day of the study. When the blood concentrations of digoxin were corrected for body weight, this difference was PATIENT F.F. Mean body composition of five obese subjects before and after weight reduction. The mean loss of total body weight was 102 pounds, of fat-free body weight 22 pounds, and the mean loss of fat was 80 pounds.
In spite of the large differences in total body weight, fat-free body weight and blood digoxin concentrations were little changed. no longer significant. These observations were interpreted as indicating that body weight was a determinant of the blood concentrations of digoxin. Additional support for this conclusion was the observation that the one elderly patient (J.R.) whose body weight (182 pounds) was greater than the mean weight of the other elderly patients and closer to that of the younger, heavier volunteers had blood concentrations of digoxin that were similar to the younger volunteers.'
Jelliffe3 has likewise stressed the importance of body weight in determining digoxin dosage. He and his associates have developed computer programs and a nomogram from which the daily maintenance dose of digoxin is calculated using the desired blood concentration, renal function, and total body weight.
The observation by Harrison and associates4 and Doherty ( [JE] Unpublished observations) that the concentration of digoxin in skeletal muscle of man and the dog is many times higher than in fat, prompted the present study. Our findings are shown diagrammatically in figure 3 . Before weight reduction, the average total body weight was 277 pounds, and the average fat-free body mass was 138 pounds. Following a mean loss of 102 pounds, there was a gross reduction in body fat but only a small reduction in fat-free body weight.
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The blood concentration of intravenously administered digoxin was similar before and after weight reduction. The problem of the interrelationship of body weight and blood concentration of digoxin may be clarified by the hypothesis that the concentration of digoxin in blood varies inversely with fat-free body weight, but is little affected by marked alterations in body weight due to adipose tissue. This hypothesis is consistent with the data from the present study as well as the study of digoxin metabolism in the elderly. Although fat-free body weight was not determined in the study of digoxin metabolism in the elderly, the younger individuals were muscular and therefore probably had a larger, fat-free body weight than the elderly subjects.
The clinical implications of this study are that digoxin dosage may be erroneously high if calculated on the basis of total body weight in obese individuals. If the individual is a large, muscular man who would be expected to have a large, fat-free body mass, then a dose of digoxin larger than normal may be needed to achieve a blood concentration equal to that given to a smaller, less well-muscled individual. However, if the patient is obese, the dose of digoxin required to achieve a certain blood concentration should be no greater than in the less obese or thin subject of comparable height who may have an equal fat-free body mass.
The findings of this study may not be applicable to cardiac glycosides such as digitoxin that are less polar or more fat soluble than digoxin. Should digitoxin be found in appreciable concentrations in adipose tissue, then the obese patient might be expected to require more digitoxin than the less obese individual to achieve similar concentrations of the drug in blood and heart.
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